# OpenAI researcher in talks to launch $2B AI drug discovery startup

OpenAI researcher Miles Wang is reportedly in discussions to found a new AI-driven drug discovery company with a potential $2 billion valuation. The move highlights the increasing intersection of advanced artificial intelligence and pharmaceutical development. This underscores the growing investor appetite for AI-biotech ventures that could accelerate the creation of new therapies.

**Importance:** 3/5

## Sources

### Technology
- [TechCrunch](https://techcrunch.com/2026/07/14/openai-researcher-miles-wang-in-talks-to-launch-ai-drug-discovery-startup-valued-at-2b/) — Wed, 15 Jul 2026 00:27:04 +0000
- [TechCrunch](https://techcrunch.com/2026/07/17/nuclear-startup-valar-atomics-in-talks-to-raise-new-funding-at-6b-valuation/) — Fri, 17 Jul 2026 19:22:00 +0000